1. Home
  2. NNNN vs AZTA Comparison

NNNN vs AZTA Comparison

Compare NNNN & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$16.79

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$23.27

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
AZTA
Founded
2021
1978
Country
Germany
United States
Employees
27
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NNNN
AZTA
Price
$16.79
$23.27
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$40.60
AVG Volume (30 Days)
21.2K
990.0K
Earning Date
04-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.52
EPS
N/A
N/A
Revenue
N/A
$593,821,000.00
Revenue This Year
N/A
$6.99
Revenue Next Year
N/A
$5.98
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.50
$15.93
52 Week High
$55.65
$41.73

Technical Indicators

Market Signals
Indicator
NNNN
AZTA
Relative Strength Index (RSI) 33.36 57.13
Support Level $14.66 $21.77
Resistance Level $31.12 $24.36
Average True Range (ATR) 3.11 0.92
MACD -0.97 0.08
Stochastic Oscillator 9.95 47.10

Price Performance

Historical Comparison
NNNN
AZTA

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

Share on Social Networks: